Verici Dx Share Discussion Threads

[wan] 29/2/2024 09:39

I note the recent news flow regarding CareDx and Natera's results (including cash balances), and perhaps most notably the following -

Natera Announces Next Phase of CareDx Patent Infringement Litigation Seeking Royalty For All Ongoing And Future AlloSure Tests
February 27, 2024

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced the next phase of proceedings in its patent infringement litigation against CareDx. The U.S. District Court for the District of Delaware will now determine if CareDx owes a royalty for future infringement related to ongoing and future AlloSure testing occurring after August 2023.

This follows a Jan. 2024 jury verdict in favor of Natera, in which the jury awarded $96.3 million in damages to Natera in lost profits and past royalties through August 2023. The jury found that CareDx’s AlloSure and AlloSeq tests infringed one of the two Natera patents asserted against CareDx and that all asserted claims of both patents are valid on various grounds.

Discovery and briefing for this next phase are expected to last through the end of summer 2024.



No such issues with Verici's technology, and strategically (partnering or acquiring) Verici must be looking attractive to numerous players....so the future looks very bright in my view.

[someuwin] 29/2/2024 09:12

Added more today.

[smackeraim] 28/2/2024 13:05

Looking like it's going to breakout from 3 month highs here

[someuwin] 28/2/2024 12:16

Upwards from here - I hope.

[wan] 28/2/2024 04:20

Looks like Harwood bought circa 8.5m shares in the placing, subsequently Harwood's holding was diluted down from 17.1% to 15.5%.

[bri15] 27/2/2024 21:08

"following the placing the companies cash runway will be extended into 2026"
time to load up here and wait for expected good news to arrive.

[smackeraim] 27/2/2024 16:33

Took bookbuild probably .. 15% Harwood Capital https://www.harwoodcapital.co.uk/about/people#!

[bloomberg2] 27/2/2024 16:30

Can't see ! Are they building or dumping

[smackeraim] 27/2/2024 16:10

Another tr1

[smackeraim] 26/2/2024 10:31

"The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage."So on point in current times. Easy takeout target imo.

[smackeraim] 22/2/2024 08:59

Yes, it bodes well. I had a feeling that this bookbuild may have been mainly accounted for. The RNS to say it was done came less than 3 hours after open that day.

[bmcollins] 22/2/2024 08:06

@smack
Indeed thes 3 plus Hargreave Hale are pretty much the AIM focussed VCT's & HH might well have bought anyway but been below a declarable stake.
Not to mention that all VCT's tend to hold some AIM shares as a counterweight to their concentration on genuine private start ups, Maven is a good example here, so with this sort of support, not to mention their industry tie ups with larger co's, Unis, this does look well set for success, thus the share price stagnation does surprise me. These VCT's do tend to be long term holders, Amati particularly so as they like to run their winners, some of their stocks were bought over a decade ago and have multiplied in price many times over so whereas on many fund raises there is a significant overhang, I don't see that here.

[adorling] 22/2/2024 07:59

Good to see another sizeable holding of 8.9% confirmed by Octopus Investments Ltd

[smackeraim] 22/2/2024 07:02

There’s another .. over half placing gone to these 3

[bmcollins] 21/2/2024 19:58

Two very well regarded VCT/small co's managers as well, seems like raising cash was no problem for VRCI with backers like these.

[smackeraim] 21/2/2024 19:01

That's roughly a 3rd of placing shares taken by two tr1

[smackeraim] 21/2/2024 18:53

A second new tr1 after close. Big support in the book build then !

[toffeeman] 21/2/2024 13:07

Thanks to Tombo for the correction!

[bmcollins] 21/2/2024 12:19

@timbo
Your reasons on why Unicorns purchase is not "passive" is precisely why I posted, having been a long term investor in vct's (including Unicorn)I couldn't,(still can't) understand why there has been no reaction.
Of course Unicorn had to pay the full price, it is their investors who you correctly pointed out that recieve the 30% rebate through tax relief and, again as you pointed out, the vct can buy under certain circumstances but once bought they could sell the next day if their is a bid, say.
Unicorn is a long standing vct manager so if they show this confidence why do we shareholders seem so lonely here ?
I just can not figure it out.
The capital raise was a success all round which shows shrewd judgement, imho, by the board.
Patience is truly a virtue.

[timbo003] 21/2/2024 11:59

Also worth noting that unlike EIS investors, VCTs do not have a minimum holding period for investee companies (for EIS investors it is 3 years). VCT shareholders do however have to hold their VCT shares for 5 years to retain the 30% tax break.

[timbo003] 21/2/2024 11:54

Unicorn cannot buy in the open market (VCTs can only buy newly issued shares if they wish to retain VCT status). They will have paid 9p/share (like the rest of us), but the Unicorn shareholders will have benefited from a 30% tax rebate when they bought their Unicorn shares, so effectively they have picked up a stake in Verici for 6.3p/ share 🙂

[smackeraim] 21/2/2024 11:18

They probably took the increase in the bookbuild, as opposed to open market. Further support

[toffeeman] 21/2/2024 11:06

Unicorn paid 6.3p per share.

They are uninterested in the share price over the next 5 years.

If the company is still independent then they may be paying dividend by then and the VCT pays them to their shareholders tax free.

If the company is acquired then Unicorn can pay out a special divi to their shareholders which again is tax free.

Treat Unicorn as a passive investor with no impact on the share price.

[bmcollins] 21/2/2024 09:59

Excuse me if I appear rather thick but after a vct greatly increasing their stake in VRCI that not only does the price not go up it actually falls back to its levels pre announcement of the size of the purchase.
What am I missing (please nobody say profit) ?

[bri15] 20/2/2024 03:28

This is due a rerate, surly.